Navigation Links
See-through 'MitoFish' opens a new window on brain diseases
Date:12/5/2012

Scientists have demonstrated a new way to investigate mechanisms at work in Alzheimer's and other neurodegenerative diseases, which also could prove useful in the search for effective drugs. For new insights, they turned to the zebrafish, which is transparent in the early stages of its life. The researchers developed a transgenic variety, the "MitoFish," that enables them to see within individual neurons of living animals how brain diseases disturb the transport of mitochondria, the power plants of the cell.

Neurodegenerative diseases such as Alzheimer's, Parkinson's, ALS (amyotrophic lateral sclerosis), and MS (multiple sclerosis) are quite different in their effects on patients' cognitive and motor functions, behavior, and prognosis. Yet on the level of individual neurons, common mechanisms can be observed that either cause or accompany nerve degeneration in a number of different diseases. One of these is a disturbance in the transport of mitochondria, organelles that play several vital roles in the life of a cell above all, delivering energy where it is needed. And in a neuron, an extremely power-hungry cell, that means moving mitochondria all the way down its longest extension, the axon. Studying mitochondria transport in other animal models of neurodegenerative disease, particularly in mice, has been revealing. But the MitoFish model opens up new possibilities.

The new model was jointly developed in the labs of Prof. Thomas Misgeld of the Technische Universitt Mnchen (TUM) and Dr. Bettina Schmid, a senior scientist of the German Center for Neurodegenerative Diseases (DZNE) based at the institute of LMU Prof. Christian Haass. "This collaboration has provided a system," Misgeld says, "with which we can try to understand the traffic rules or the life cycle of a given organelle, in this case mitochondria, in the context of a nerve cell that's existing in its physiological environment, where it is developing and changing. Most of these t
'/>"/>

Contact: Patrick Regan
regan@zv.tum.de
49-089-289-10515
Technische Universitaet Muenchen
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Cancer therapy -- Nanokey opens tumors to attack
2. McDivitt Law Firm Opens Office to Fellow Attorneys Affected by Colorado Springs Wildfires
3. Tracy, California Coast Dental Office Opens
4. 101 Mobility Opens Franchise in Roanoke/Lynchburg Market
5. Novel Natural Sciences Repository Opens Web Portal
6. Experimental drug may extend therapeutic window for stroke
7. GSW Telnet Server for Windows Partners with MobileDemand
8. The first day of development -- a window to successful pregnancy
9. In US first, Johns Hopkins surgeons implant brain pacemaker for Alzheimers disease
10. The radical restructuring of brain networks in comatose patients
11. Barrow researchers successfully destroy brain tumor cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
See-through 'MitoFish' opens a new window on brain diseases
(Date:5/6/2015)... May 06, 2015 The Beryl Institute ... of Patient Experience Journal (PXJ), an international, open ... around understanding and improving patient experience. The second volume ... experience conversation globally, helps align the voices engaged and ... , Published in association with The Beryl Institute, Volume ...
(Date:5/6/2015)... 06, 2015 Is Colorado’s legal cannabis ... month the Centennial State will mark the 18-month milestone ... to adults. And while Colorado’s legal marijuana industry has ... time, it’s also facing some new challenges. , For ... facing shortages, especially in the wake of last month’s ...
(Date:5/6/2015)... vcfo, a specialized consulting firm that provides access ... optimize business performance and productivity, announced the additions of ... Both Lynch and Scheaffer have more than 25 years ... are delighted to add Jack and Mike to the ... in financial management and leadership, Mike and Jack will ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup ... China, has successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction ... Anitoa’s handheld qPCR is shown to be capable of ... hepatitis B, C, and E. Coli. This qPCR system ... and over 9 orders of magnitude dynamic range. ...
(Date:5/6/2015)... 2015 Locally owned, Greek olive oil producer ... past week as having one the best Extra Virgin Olive ... the Peloponnese region of Greece and known as Laconiko ... category of Medium Olive Oil, which is defined by the ... With over 700 producer applicants from 25 different countries applying, ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2
... non-invasive way to determine the existence and extent of ... pharmacologic strategies to combat the condition. These findings are ... by John Wiley & Sons on behalf of the ... The article is also available online at Wiley Interscience ...
... Dr. Yukai He wants to put cancer in the bulls eye. ... Cancer Center immunologist says of the scary reality that cancer cells ... doesnt always see cancer as a horrific invader. , Tumors and ... main player in anti-tumor immunity, cohabitate for many years before the ...
... disability in the United States. Over the next 25 ... toll of this disease will escalate. To have a ... on our nations health care and public health systems, estimating ... arthritisis critical. , The National Arthritis Data Workgroup was formed ...
... R. Bloomberg, Health Commissioner Dr. Thomas R. Frieden, and Consumer ... 2007 New York City Youth Risk Behavior Survey (YRBS) showing ... 20 percent between 2005 and 2007. The citys teen smoking ... six years, from 17.6 percent in 2001 to 8.5 percent ...
... in red wine grapes may significantly reduce the ability ... published recently in the Journal of Agricultural and Food ... large amounts in fermented seeds and skins cast away ... bacteria to contribute to tooth decay. Beyond cavities, the ...
... of Medicine (BUSM) have found that vitamin D2 is equally ... The study appears online in the December 2007 issue ... studied healthy adults aged 18-84 who received either placebo, 1,000 ... D2, or 500 IU of vitamin D2 plus 500 IU ...
Cached Medicine News:Health News:MRI techniques evolving towards better assessment of liver fibrosis 2Health News:New strategies work to put cancer on the firing line 2Health News:New strategies work to put cancer on the firing line 3Health News:The prevalence and impact of arthritis and other rheumatic conditions in the United States 2Health News:The prevalence and impact of arthritis and other rheumatic conditions in the United States 3Health News:Smoking rate among New York City teens was lowest on record in 2007 2Health News:Smoking rate among New York City teens was lowest on record in 2007 3Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 2Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 3Health News:Winemaking waste proves effective against disease-causing bacteria in early studies 4Health News:Vitamin D2 is as effective as vitamin D3 in maintaining concentrations of 25-hydroxyvitamin D 2
(Date:5/6/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Chromatography (Instruments ... report to their offering. Chromatography ... and identifying the component of a complex mixture ... Over the decades the scientists have considered chromatography ...
(Date:5/6/2015)... May 6, 2015   CEFALY Technology , the ... device specifically authorized for use prior to the onset ... in migraine treatment at the EUROHEADPAIN - Midterm Meeting ... Valencia, Spain , from May 14-17, 2015. ... of EUROHEADPAIN, a major European research project focused on ...
(Date:5/6/2015)... Advanced wound care - assess products, developments, ... future hold for the advanced wound care ... potential revenues to 2025, assessing data, trends, opportunities and ... provides 115 tables, charts, and graphs covering 12 distinct ... industry and the future market prospects. You will see ...
Breaking Medicine Technology:Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6
... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today ... exchange up to $180,000,000 in aggregate principal amount of outstanding ... like principal amount of new 2.875% Series 2012 Convertible Senior ... name of the New Notes has been amended from the ...
... Pa., Jan. 3, 2012  The board of directors of Kensey ... the board has declared a cash dividend of $0.25 ... stockholders of record on January 31, 2012.  The dividend will ... initial dividend under a new policy whereby the board of ...
Cached Medicine Technology:PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 2Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 3Kensey Nash Corporation Adopts Cash Dividend Policy; Declares Initial Quarterly Dividend of $0.25 per Share 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: